Opportunity Information: Apply for RFA CA 19 027
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) (RFA-CA-19-027) is a National Cancer Institute (NCI) grant opportunity designed specifically for currently funded NCI P50 Specialized Center programs that want to submit a revision application (previously referred to as a competing revision). The central idea is to help established cancer research centers move faster or broaden the impact of their existing, peer-reviewed center research by adding a new technical approach or instrument that was developed with support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Rather than funding an entirely new center or a brand-new standalone project, this FOA focuses on targeted expansions to the active parent award that meaningfully enhance what the center is already doing.
The purpose of the program is twofold: first, to accelerate progress on the parent P50 study by incorporating an IMAT-developed technology that can deepen, refine, or extend the original research questions in one or more of the center's projects; and second, to promote independent validation of emerging technologies. In practice, this means the NCI is trying to bridge the gap between promising, innovative tools and their real-world usefulness in broader cancer research settings. By supporting independent testing and application within active P50 centers, the FOA aims to demonstrate reliability, suitability, and value for the larger research community, not just for the group that originally invented the technology.
A defining feature of the opportunity is its emphasis on interdisciplinary collaboration. Because IMAT technologies often sit at the intersection of engineering, computational science, molecular measurement, and cancer biology or clinical research, the FOA encourages teams to bring together diverse expertise to integrate a novel method into ongoing cancer research. The revisions are meant to be practical and additive: they should either expand the scope of specific projects under the P50 or remove bottlenecks and accelerate discovery by enabling measurements or analyses that were not previously feasible within the parent study.
The funding mechanism is a discretionary grant administered by the U.S. Department of Health and Human Services through the NIH (specifically NCI). The activity category is listed under Education and Health, with CFDA number 93.394. Clinical trials are optional under this FOA, meaning applicants may propose work that includes a clinical trial component if it fits the revision aims and the parent center structure, but a clinical trial is not required.
In terms of scale and competitiveness, the FOA anticipated a small number of awards (expected awards: 3), reflecting a targeted initiative rather than a broad-based funding program. The maximum award amount listed is $150,000, which reinforces that these are intended to be focused revision efforts that add a defined technological component to an existing, well-supported P50 program, rather than large multi-year expansions comparable to a new center award.
Eligibility is broad in the general NIH sense and includes many organization types (such as public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations, small businesses, and various government and tribal entities). However, the practical eligibility constraint is that the applicant must already hold an active NCI P50 Specialized Center award that can serve as the parent grant for the revision, since the FOA is explicitly for revision applications tied to currently funded P50 centers.
Key administrative details include the FOA creation date of January 7, 2019, and an original closing date of September 27, 2019. Overall, the opportunity is best understood as a targeted NCI effort to speed adoption and rigorous testing of IMAT-enabled innovations inside established cancer research centers, with the near-term goal of accelerating progress on the parent center projects and the longer-term goal of moving novel technologies closer to routine use by appropriate cancer research communities.Apply for RFA CA 19 027
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394.
- This funding opportunity was created on Jan 07, 2019.
- Applicants must submit their applications by Sep 27, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: DoD Breast Cancer, Breakthrough Fellowship Award
Previous opportunity: Lead-Based Paint Capital Fund Program (LBPCF) - Update and Reissue
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 19 027
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 19 027) also looked into and applied for these:
| Funding Opportunity |
|---|
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 19 025 Funding Number: RFA CA 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 19 026 Funding Number: RFA CA 19 026 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 19 023 Funding Number: RFA CA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 19 024 Funding Number: RFA CA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Distance Learning and Telemedicine Grants. Apply for RUS 19 02 DLT Funding Number: RUS 19 02 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Distance Learning and Telemedicine Grants--Opioid. Apply for RUS 19 01 DLT Funding Number: RUS 19 01 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Apply for RFA CA 19 034 Funding Number: RFA CA 19 034 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) Apply for RFA CA 19 035 Funding Number: RFA CA 19 035 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| American Schools and Hospitals Abroad Program Worldwide Apply for 72ASHA19RFA00001 Funding Number: 72ASHA19RFA00001 Agency: Agency for International Development Category: Education, Health Funding Amount: $2,000,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) Apply for RFA CA 19 062 Funding Number: RFA CA 19 062 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) Apply for RFA CA 19 061 Funding Number: RFA CA 19 061 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional) Apply for RFA CA 19 063 Funding Number: RFA CA 19 063 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA DA 20 024 Funding Number: RFA DA 20 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required) Apply for RFA CA 19 059 Funding Number: RFA CA 19 059 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $3,300,000 |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 20 027 Funding Number: RFA DA 20 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network (NCTN)(U24 Clinical Trial Not Allowed) Apply for RFA CA 20 002 Funding Number: RFA CA 20 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $3,000,000 |
| Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional) Apply for RFA CA 20 006 Funding Number: RFA CA 20 006 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 20 017 Funding Number: RFA CA 20 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 20 020 Funding Number: RFA CA 20 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 20 019 Funding Number: RFA CA 20 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.